153 related articles for article (PubMed ID: 23169491)
1. Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.
Isidor B; Bourdeaut F; Lafon D; Plessis G; Lacaze E; Kannengiesser C; Rossignol S; Pichon O; Briand A; Martin-Coignard D; Piccione M; David A; Delattre O; Jeanpierre C; Sévenet N; Le Caignec C
Eur J Hum Genet; 2013 Jul; 21(7):784-7. PubMed ID: 23169491
[TBL] [Abstract][Full Text] [Related]
2. Wilms Tumor Associated With the 9q22.3 Microdeletion Syndrome: 2 New Case Reports and a Review of The Literature.
Cayrol J; Nightingale M; Challis J; Campbell M; Sullivan M; Heloury Y
J Pediatr Hematol Oncol; 2019 Nov; 41(8):e517-e520. PubMed ID: 30371535
[TBL] [Abstract][Full Text] [Related]
3. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.
Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A
Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115
[TBL] [Abstract][Full Text] [Related]
4. Microdeletion 9q22.3 syndrome includes metopic craniosynostosis, hydrocephalus, macrosomia, and developmental delay.
Muller EA; Aradhya S; Atkin JF; Carmany EP; Elliott AM; Chudley AE; Clark RD; Everman DB; Garner S; Hall BD; Herman GE; Kivuva E; Ramanathan S; Stevenson DA; Stockton DW; Hudgins L
Am J Med Genet A; 2012 Feb; 158A(2):391-9. PubMed ID: 22190277
[TBL] [Abstract][Full Text] [Related]
5. A familial case of overgrowth syndrome caused by a 9q22.3 microdeletion in a mother and daughter.
Yamada H; Shimura M; Takahashi H; Nara S; Morishima Y; Go S; Miyashita T; Numabe H; Kawashima H
Eur J Med Genet; 2020 May; 63(5):103872. PubMed ID: 32028043
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of microdeletion 9q22.3 (pat).
Shimojima K; Adachi M; Tanaka M; Tanaka Y; Kurosawa K; Yamamoto T
Clin Genet; 2009 Apr; 75(4):384-93. PubMed ID: 19320658
[TBL] [Abstract][Full Text] [Related]
7. Perlman syndrome: report, prenatal findings and review.
Alessandri JL; Cuillier F; Ramful D; Ernould S; Robin S; de Napoli-Cocci S; Rivière JP; Rossignol S
Am J Med Genet A; 2008 Oct; 146A(19):2532-7. PubMed ID: 18780370
[TBL] [Abstract][Full Text] [Related]
8. Beck-Wiedemann syndrome and Wilms' tumour.
Ward A
Mol Hum Reprod; 1997 Feb; 3(2):157-68. PubMed ID: 9239720
[TBL] [Abstract][Full Text] [Related]
9. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
10. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.
Newsham I; Kindler-Röhrborn A; Daub D; Cavenee W
Genes Chromosomes Cancer; 1995 Jan; 12(1):1-7. PubMed ID: 7534105
[TBL] [Abstract][Full Text] [Related]
11. Long term survival of a patient with Perlman syndrome due to novel compound heterozygous missense mutations in RNB domain of DIS3L2.
Soma N; Higashimoto K; Imamura M; Saitoh A; Soejima H; Nagasaki K
Am J Med Genet A; 2017 Apr; 173(4):1077-1081. PubMed ID: 28328139
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.
Astuti D; Morris MR; Cooper WN; Staals RH; Wake NC; Fews GA; Gill H; Gentle D; Shuib S; Ricketts CJ; Cole T; van Essen AJ; van Lingen RA; Neri G; Opitz JM; Rump P; Stolte-Dijkstra I; Müller F; Pruijn GJ; Latif F; Maher ER
Nat Genet; 2012 Feb; 44(3):277-84. PubMed ID: 22306653
[TBL] [Abstract][Full Text] [Related]
13. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
14. Postnatal diagnosis of 9q interstitial imbalances involving PTCH1, resulting from a familial intrachromosomal insertion.
Blanchard M; Dubourg C; Pasquier L; Odent S; Lucas J; Quélin C; Launay E; Akloul L; Henry C; Belaud-Rotureau MA; Dugay F; Jaillard S
Eur J Med Genet; 2014 Apr; 57(5):195-9. PubMed ID: 24486987
[TBL] [Abstract][Full Text] [Related]
15. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
16. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics and molecular genetics of Wilms' tumor of childhood.
Slater RM; Mannens MM
Cancer Genet Cytogenet; 1992 Jul; 61(2):111-21. PubMed ID: 1322233
[TBL] [Abstract][Full Text] [Related]
18. Familial 9q22.3 microduplication spanning PTCH1 causes short stature syndrome with mild intellectual disability and dysmorphic features.
Izumi K; Hahn A; Christ L; Curtis C; Neilson DE
Am J Med Genet A; 2011 Jun; 155A(6):1384-9. PubMed ID: 21567912
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
